Letolizumab ELISA Kit

Introduction

Letolizumab is a humanized monoclonal antibody that targets the CD25 subunit of the interleukin-2 receptor (IL-2R). It is currently being investigated as a potential therapeutic agent for various autoimmune diseases and cancer. The Letolizumab ELISA Kit is a reliable and sensitive tool for the detection and quantification of this antibody in biological samples.

Structure of Letolizumab

Letolizumab is a recombinant human IgG1 monoclonal antibody that is composed of two heavy chains and two light chains. It has a molecular weight of approximately 150 kDa and contains four constant regions (Fc) and four variable regions (Fab). The antibody is produced using Chinese hamster ovary (CHO) cells and has a high degree of homology with human IgG1. Letolizumab specifically binds to the CD25 subunit of the IL-2R with high affinity and inhibits the binding of interleukin-2 (IL-2) to its receptor.

Mechanism of Action

The IL-2R is expressed on the surface of activated T cells and plays a crucial role in the activation and proliferation of these cells. Letolizumab blocks the interaction between IL-2 and its receptor, thereby inhibiting the downstream signaling pathways involved in T cell activation and proliferation. This leads to a decrease in the number of activated T cells and a reduction in the inflammatory response. Letolizumab has also been shown to induce antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) against CD25-positive cells, further contributing to its therapeutic effects.

Applications of Letolizumab ELISA Kit

The Letolizumab ELISA Kit is a valuable tool for the detection and quantification of this antibody in various biological samples, including serum, plasma, and cell culture supernatants. It is commonly used in preclinical and clinical studies to monitor the levels of Letolizumab in patients receiving treatment. The kit is also used in the development and production of Letolizumab for quality control purposes.

Advantages of Letolizumab ELISA Kit

The Letolizumab ELISA Kit offers several advantages over other methods of detecting and quantifying this antibody. It is a highly sensitive and specific assay that can detect Letolizumab at very low concentrations. The kit is also easy to use, with a simple and straightforward protocol that can be completed in a few hours. It is a cost-effective option compared to other methods, making it suitable for large-scale studies. Additionally, the Letolizumab ELISA Kit has been validated for use with various biological samples, ensuring reliable and accurate results.

Clinical Significance

Letolizumab is currently being investigated as a potential therapeutic agent for several autoimmune diseases, including rheumatoid arthritis, psoriasis, and multiple sclerosis. It has also shown promising results in clinical trials for the treatment of certain types of cancer, such as non-small cell lung cancer and renal cell carcinoma. The Letolizumab ELISA Kit plays a crucial role in these studies by providing a means to accurately measure the levels of Letolizumab in patients and monitor its efficacy.

Conclusion

The Letolizumab ELISA Kit is a valuable tool for the detection and quantification of this antibody in various biological samples. It offers several advantages over other methods and has significant clinical significance in the development and use of Letolizumab as a therapeutic agent. With its high sensitivity and specificity, the Letolizumab ELISA Kit is a crucial component in the research and development of this promising antibody.